TDP-43 proteinopathy
MONDO:0700038Disease characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.
2 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
Can a new PET tracer light up the protein behind some dementias and ALS?
Diagnosis Recruiting nowThis early-phase trial is testing whether an experimental imaging agent called [18F]ACI-19626 can safely and reliably detect abnormal clumps of a protein called TDP-43 in the brain using PET scans. TDP-43 buildup is linked to certain forms of dementia, such as frontotemporal deme…
Early phase 1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
AI hunts for early clues to Parkinson's and Alzheimer's progression
Knowledge-focused Recruiting nowThis study follows 600 people with neurodegenerative diseases such as Parkinson's, Alzheimer's, and related conditions over 1 to 10 years. Researchers collect data from routine clinical exams, brain imaging, movement analysis, and blood tests. They use statistical tools and artif…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC